首页> 外文OA文献 >Benefit vs potential harm of genome‐wide prenatal cfDNA testing requires further investigation and should not be dismissed based on current data

【2h】

Benefit vs potential harm of genome‐wide prenatal cfDNA testing requires further investigation and should not be dismissed based on current data

机译：益处与基因组产前的危害CFDNA测试需要进一步调查，不应根据当前数据解雇

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
M. N. Bekker; L. Henneman; M. V. E. Macville; E. A. Sistermans; R. J. H. Galjaard;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Benefit vs vs potential harm of genome‐wide prenatal cfDNA cfDNA testing requires further investigation and should not be dismissed based on current data [J] . Ultrasound in obstetrics & gynecology: the official journal of the International Society of Ultrasound in Obstetrics and Gynecology . 2020,第5期

机译：益处VS与基因组产前的潜在危害CFDNA测试需要进一步调查，不应根据当前数据解雇
2. The clinical benefit of genome-wide cfDNA testing cannot be extrapolated from CVS data [J] . Genetics in medicine . 2020,第3期

机译：基因组的CFDNA测试的临床益处不能从CVS数据推断出来
3. The clinical benefit of genome-wide cfDNA testing cannot be extrapolated from CVS data Response [J] . Genetics in medicine . 2020,第3期

机译：基因组的CFDNA测试的临床益处不能从CVS数据响应外推开
4. AN INVESTIGATION INTO THE CORRELATION BETWEEN HALF CELL, CURRENT INJECTION TESTING AND THE CURRENT REQUIRED FOR PROTECTION [C] . P. Nichols, J. Gastal, B. Ward Annual Conference of the Australasian Corrosion Association . 2018

机译：对半电池，电流喷射测试与保护所需电流相关的调查
5. Metabolic network construction based on the genome of the marine diatom Thalassiosira pseudonana and the analysis of genome-wide transcriptome data to investigate triacylglyceride accumulation [D] . Parker, Karen R. 2013

机译：基于海洋硅藻拟南芥基因组的代谢网络构建和全基因组转录组数据分析，以研究甘油三酯的积累
6. Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high-risk women based on a US population [O] . Ken Song, Thomas J. Musci, Aaron B. Caughey -1

机译：基于美国人群的高风险女性使用cfDNA分析进行无创产前检测的临床效用和成本
7. OP22.04: Non-invasive prenatal testing (NIPT) for 22q11.2 deletion syndrome using a targeted microarray-based cell-free DNA (cfDNA) test [O] . M. Schmid, E. Wang, P. Bogard, 2017

机译：OP22.04：使用靶向微阵列的无细胞DNA（CFDNA）试验22Q11.2缺失综合征的非侵入性产前试验（NIPT）

Benefit vs potential harm of genome‐wide prenatal cfDNA testing requires further investigation and should not be dismissed based on current data

著录项

引文网络

相似文献

相关主题

期刊订阅